Alport Syndrome Pipeline Insight 2024, Featuring Eloxx Pharmaceuticals, Chinook Therapeutic, River 3 Renal Corp., Travere Therapeutics and Reata Pharmaceuticals
11 avr. 2024 11h04 HE
|
Research and Markets
Dublin, April 11, 2024 (GLOBE NEWSWIRE) -- The "Alport Syndrome - Pipeline Insight, 2024" has been added to ResearchAndMarkets.com's offering.The "Alport Syndrome - Pipeline Insight, 2024," report...